4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-012120
SVP & Chief Commercial Officer sold 15,358 shares at $22.37 ($343,558)
From the SEC's structured data for this filing
Trades in this filing
NORTHCOTT JOHN · SVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-16 | Sale : show line 1 in the form | −15,358 | $22.37 | $343,558 | 213,192 | D |
| Open-market sales · 15,358 sh · avg $22.37 · $343,558 | ||||||
Loading xslF345X03/doc4.xml…